The Medical Letter on Drugs and Therapeutics
FROM
ISSUE838
ISSUE838
February 22, 1991
Doxazosin For Treatment of Hypertension
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Doxazosin For Treatment of Hypertension
February 22, 1991 (Issue: 838)
Doxazosin (mesylate - Roerig), an alpha1-adrenergic receptor blocker similar to prazosin (Minipress, and others) and terazosin (Hytrin), was recently approved by the US Food and Drug Administration for treatment of hypertension.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.